Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Extension Study for Continued Safety and Efficacy Evaluation of Azeliragon in Patients With Mild Alzheimer's Disease

NCT02916056 is registered in ClinicalTrials.gov with vTv Therapeutics as lead sponsor.

NCT NCT02916056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02916056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Extension Study for Continued Safety and Efficacy Evaluation of Azeliragon in Patients With Mild Alzheimer's Disease
Lead sponsor
vTv Therapeutics
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2016
Completion date
June 1, 2018
Enrollment
297 (actual)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease